Correlation Between BioPorto and Orphazyme

Can any of the company-specific risk be diversified away by investing in both BioPorto and Orphazyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioPorto and Orphazyme into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioPorto and Orphazyme AS, you can compare the effects of market volatilities on BioPorto and Orphazyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioPorto with a short position of Orphazyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioPorto and Orphazyme.

Diversification Opportunities for BioPorto and Orphazyme

-0.09

Correlation Coefficient

BioPorto  Orphazyme

Good diversification

The 3 months correlation between BioPorto and Orphazyme is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding BioPorto and Orphazyme AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orphazyme AS and BioPorto is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioPorto are associated (or correlated) with Orphazyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orphazyme AS has no effect on the direction of BioPorto i.e., BioPorto and Orphazyme go up and down completely randomly.

Pair Corralation between BioPorto and Orphazyme

Assuming the 90 days trading horizon BioPorto is expected to under-perform the Orphazyme. But the stock apears to be less risky and, when comparing its historical volatility, BioPorto is 1.62 times less risky than Orphazyme. The stock trades about -0.13 of its potential returns per unit of risk. The Orphazyme AS is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  85,000  in Orphazyme AS on September 3, 2024 and sell it today you would earn a total of  13,000  from holding Orphazyme AS or generate 15.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioPorto  vs.  Orphazyme AS

BioPorto

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioPorto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Orphazyme AS

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Orphazyme AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Orphazyme exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioPorto and Orphazyme

The main advantage of trading using opposite BioPorto and Orphazyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioPorto position performs unexpectedly, Orphazyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orphazyme will offset losses from the drop in Orphazyme's long position.

The idea behind BioPorto and Orphazyme AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..